Published in Eur J Surg Oncol on April 01, 1994
Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. Br J Cancer (2000) 1.55
Role of arginine and its methylated derivatives in cancer biology and treatment. Cancer Cell Int (2001) 0.79
Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb (1996) 2.00
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol (2000) 1.69
Glomus tumour: an analysis of 43 patients and review of the literature. Br J Surg (1992) 1.68
Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions? Eur J Clin Pharmacol (2011) 1.62
Self-expanding metal stents in the management of colorectal carcinoma--a preliminary report. Clin Radiol (1998) 1.56
Surgical management of the septic complications of diverticular disease. Ann R Coll Surg Engl (1995) 1.44
Comparison of the direct antiglobulin rosetting reaction with the mixed antiglobulin rosetting reaction for the detection of immunoglobulin on lymphocytes. J Immunol Methods (1977) 1.42
Peri-operative acute phase response and cytokine releasein women with breast cancer: modulation bypolyadenylic-polyuridylic acid. Eur J Surg Oncol (1999) 1.41
Vaccination therapy in malignant disease. Surgeon (2006) 1.40
Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg (1999) 1.38
Natural killer cells and cancer. Cancer (1996) 1.33
Cognitive performance and mood after a weekend on call in a surgical unit. Br J Surg (1997) 1.30
Varicocoele caused by a pancreatic pseudocyst. Gut (1983) 1.21
Nutrition and malignant disease: implications for surgical practice. Br J Surg (1992) 1.15
Hidden dangers of sliced bread. Br Med J (Clin Res Ed) (1984) 1.12
The accuracy of "one-stop" diagnosis for 1,110 patients presenting to a symptomatic breast clinic. J R Coll Surg Edinb (1999) 1.11
The effects of smoking on fracture healing. Surgeon (2010) 1.11
Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb (2000) 1.09
Breast cancer in women aged 35 and under: prognosis and survival. J R Coll Surg Edinb (2002) 1.09
Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Clin Sci (Lond) (1993) 1.08
T and B lymphocyte populations in human normal lymph node, regional tumour lymph node and inflammatory lymph node. Int Arch Allergy Appl Immunol (1976) 1.07
Measurement of albumin synthesis in humans: a new approach employing stable isotopes. Am J Physiol (1990) 1.05
Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease. Int J Cancer (1978) 1.05
Enterolith obstruction of the small bowel. J R Coll Surg Edinb (1985) 1.04
Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. Br J Cancer (1999) 1.02
Outcome in colorectal adenocarcinoma: two seven-year studies of a population. BMJ (1993) 1.02
Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin Cancer Res (2000) 1.01
Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity. Br J Cancer (1981) 1.01
Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr (2005) 1.00
Interleukin 2 therapy in cancer: identification of responders. Br J Cancer (1992) 1.00
The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat (2010) 1.00
Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett (2002) 1.00
Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet (1991) 0.98
Carcinoid tumour of the gall bladder: two case reports and a review of published works. Gut (1993) 0.98
Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. Eur J Clin Nutr (1994) 0.98
Haemangiopericytoma of the greater omentum. Eur J Surg Oncol (1995) 0.97
Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy. Am J Surg (1998) 0.97
Characterisation of macrophages infiltrating human mammary carcinomas. Br J Cancer (1985) 0.96
Characterization of the phagocytic cells isolated from the human placenta. J Reticuloendothel Soc (1982) 0.96
Characterization of the human natural killer (NK) cell in blood and lymphoid organs. Int J Cancer (1978) 0.94
Oestrogen receptor concentration and macrophage infiltration in human breast cancer. Eur J Surg Oncol (1986) 0.94
Surface characteristics of the human K (killer) lymphocyte. Int Arch Allergy Appl Immunol (1977) 0.93
Measurement of tumour protein synthesis in vivo in human colorectal and breast cancer and its variability in separate biopsies from the same tumour. Clin Sci (Lond) (1991) 0.93
Correlation of serum cytokine and acute phase reactant levels with alterations in weight and serum albumin in patients receiving immunotherapy with recombinant IL-2. Clin Exp Immunol (1994) 0.92
Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). Surgeon (2003) 0.92
Interleukin 2 receptor expression and interleukin 2 localisation in human solid tumor cells in situ and in vitro: evidence for a direct role in the regulation of tumour cell proliferation. Int J Cancer (1995) 0.91
Nutritional pharmacology and malignant disease: a therapeutic modality in patients with cancer. Br J Surg (1996) 0.91
Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. Ann Surg (1998) 0.91
Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer. Eur J Cancer (1999) 0.91
Chronic preoperative pain and psychological robustness predict acute postoperative pain outcomes after surgery for breast cancer. Br J Cancer (2012) 0.91
Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration. Ann Oncol (2006) 0.90
Minimal modulation of lymphocyte and natural killer cell subsets following minimal access surgery. Am J Surg (1999) 0.90
Epidermal growth factor receptor expression in colorectal cancer. Br J Surg (1990) 0.90
Neoadjuvant chemotherapy in women with large and locally advanced breast cancer: chemoresistance and prediction of response to drug therapy. Surgeon (2006) 0.90
Antibody-dependent cellular cytotoxicity in the rat, rabbit, and guinea pig: relationship of killer (K) cell activity with the presence of Fc+ C3- and Fc+ C3+ lymphocytes. Cell Immunol (1979) 0.90
What is achieved by mammographic surveillance after breast conservation treatment for breast cancer? Am J Surg (2001) 0.90
Lymphoreticular cells in human brain tumours and in normal brain. Br J Cancer (1982) 0.90
Immunohistochemical detection of epidermal growth factor receptors on human colonic carcinomas. Br J Cancer (1990) 0.89
Stimulation of human breast cancers by dietary L-arginine. Clin Sci (Lond) (1992) 0.89
Complications of intravenous therapy: reduction by buffering of intravenous fluid preparation. Med J Aust (1977) 0.89
Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest (2000) 0.89
Killer cell (K) activity in human normal lymph node, regional tumour lymph node and inflammatory lymph node. Int Arch Allergy Appl Immunol (1977) 0.89
Femoral hernia: mortality and morbidity following elective and emergency surgery. J R Coll Surg Edinb (1991) 0.89
Acute phase proteins in patients with large and locally advanced breast cancer treated with neo-adjuvant chemotherapy: response and survival. Int J Oncol (1998) 0.88
Expandable metal stent application in obstructing carcinoma of the proximal colon: report of a case. Dis Colon Rectum (1997) 0.87
Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (I). Surgeon (2003) 0.87
Distal procto-colitis, natural cytotoxicity, and essential fatty acids. Am J Gastroenterol (1998) 0.87
T-lymphocyte and B-lymphocyte subpopulations infiltrating human mammary carcinomas. J Natl Cancer Inst (1982) 0.87
Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg (1994) 0.86
In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model. Br J Cancer (1999) 0.86
Psychological assessment and intervention: future prospects for women with breast cancer. Semin Surg Oncol (1996) 0.86
Antibody-dependent cellular cytotoxicity and natural cytotoxicity: effect of pre-treatment of human lymphocytes with deionised water and ammonium chloride. J Immunol Methods (1978) 0.86
Immune suppression and isolated severe head injury: a significant clinical problem. Br J Neurosurg (2003) 0.86
A high macrophage content in human breast cancer is not associated with favourable prognostic factors. Br J Surg (1984) 0.86